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Abstract
Toxoplasma gondii has evolved a number of strategies to evade immune responses in its
many hosts. Previous genetic mapping of crosses between clonal type 1, 2, and 3 strains of
T. gondii, which are prevalent in Europe and North America, identified two rhoptry proteins,
ROP5 and ROP18, that function together to block innate immune mechanisms activated by
interferon gamma (IFNg) in murine hosts. However, the contribution of these and other viru-
lence factors in more genetically divergent South American strains is unknown. Here we uti-
lized a cross between the intermediately virulent North American type 2 ME49 strain and
the highly virulent South American type 10 VAND strain to map the genetic basis for differ-
ences in virulence in the mouse. Quantitative trait locus (QTL) analysis of this new cross
identified one peak that spanned the ROP5 locus on chromosome XII. CRISPR-Cas9 medi-
ated deletion of all copies of ROP5 in the VAND strain rendered it avirulent and complemen-
tation confirmed that ROP5 is the major virulence factor accounting for differences between
type 2 and type 10 strains. To extend these observations to other virulent South American
strains representing distinct genetic populations, we knocked out ROP5 in type 8 TgCtBr5
and type 4 TgCtBr18 strains, resulting in complete loss of virulence in both backgrounds.
Consistent with this, polymorphisms that show strong signatures of positive selection in
ROP5 were shown to correspond to regions known to interface with host immunity factors.
Because ROP5 and ROP18 function together to resist innate immune mechanisms, and a
significant interaction between them was identified in a two-locus scan, we also assessed
the role of ROP18 in the virulence of South American strains. Deletion of ROP18 in South
American type 4, 8, and 10 strains resulted in complete attenuation in contrast to a partial
loss of virulence seen for ROP18 knockouts in previously described type 1 parasites. These
data show that ROP5 and ROP18 are conserved virulence factors in genetically diverse
strains from North and South America, suggesting they evolved to resist innate immune
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defenses in ancestral T. gondii strains, and they have subsequently diversified under posi-
tive selection.
Author Summary
Parasites and the hosts they infect are in constant struggle with each other for survival. On
the one hand, the host needs to control parasite growth, while the parasite needs to evade
the host response long enough to allow for efficient transmission. The parasite Toxoplasma
gondii has evolved virulence factors ROP5 and ROP18 to evade innate immune mecha-
nisms of its natural intermediate host, small rodents. These genes were initially identified
in clonal parasite types isolated from Europe and North America, but the factors that con-
tribute to virulence in genetically divergent South American strains have not been tested.
Here we used forward and reverse genetic analyses to show that ROP5 and ROP18 are also
major virulence factors in genetically distinct virulent South American strains. Given that
ROP5 and ROP18 function as virulence factors in strains from North America, Europe,
and South America they likely acquired their functions before Toxoplasma gondii radiated
into its present global population structure.
Introduction
Intracellular parasites have to contend with immune responses mounted by the hosts they
infect if they are to survive long enough to effectively transmit. The parasite Toxoplasma gondii
is one of the more successful parasites in terms of transmission as it can infect all mammals
and many birds [1], both of which serve as intermediate hosts where the parasite propagates
asexually. The parasite undergoes sexual recombination only within the intestinal tract of
members of the Felidae family when these predators ingest chronically infected intermediate
hosts [2]. Transmission by this predator-prey life cycle has shaped the co-evolution of parasite
virulence factors and host responses.
T. gondii readily infects humans but mainly causes disease in situations where the immune
system has become compromised, although associations between parasite genotype and disease
severity may also occur in healthy individuals [3]. The association of virulence with parasite
genotypes has been more fully investigated in laboratory mice, where this trait can be more eas-
ily assessed and where the parasite has likely had more opportunities to evolve within a host
that is common prey of cats. Initially it was shown that parasite isolates from Europe and
North America differed in their ability to cause disease in laboratory mice. Type 1 strains lead
to lethal infection in all conventional strains of laboratory mice including outbred animals
(LD100 = 1) during the first two weeks of infection (i.e. the acute phase), and any survivors
observed at low inoculum are invariably not infected (i.e. they remain serologically negative)
[4,5,6]. In contrast, type 2 strains show intermediate virulence (LD50 varies with mouse strain,
although these strain generally do not cause mortality in outbred lines), and type 3 strains are
avirulent (they are not lethal in inbred mice at any dose), respectively [4,5,6]. These phenotypic
differences prompted the generation of genetic crosses between these three strain types, result-
ing in the identification of the rhoptry kinase ROP18 as a virulence factor in genetic crosses
between type 1 and type 3 or between type 2 and type 3 strains [7,8], and the rhoptry pseudoki-
nase ROP5 as a virulence factor in genetic crosses between type 2 and 3 or between type 1 and
2 strains [9,10]. Together these proteins are involved in resisting innate immune mechanisms
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that are induced by IFNg stimulation [11]. The parasite secretes ROP5 and ROP18 into the
host cell during invasion where they co-localize to the surface of the parasitophorous vacuole
[12]. ROP18 is tethered to the vacuole membrane by an N-terminal low complexity region [13]
and this association is required for its virulence enhancing properties [14].
At the vacuole surface, ROP18 phosphorylates host immune-related GTPase (IRGs) and
prevents them from accumulating on the membrane and destroying the parasite vacuole
[12,15]. The association of ROP18 with ROP5 increases the phosphorylation activity of ROP18
[16], and may also make substrates available to the kinase by binding to members of the IRG
family [17,18,19]. Biochemical studies subsequently showed that ROP5 also associates with
ROP17, and that this kinase works synergistically with ROP18 to phosphorylate and block
IRGs [20]. Deletion of either ROP17 or ROP18 alone leads to a modest attenuation in the type
I RH strain, evident as a delay in time until death; however, mice still succumb to low challenge
doses (i.e. 100 parasites). In contrast, deletion of both ROP17 and ROP18 leads a marked atten-
uation of virulence where mice survive high challenge does ( 105 parasites) [20], similar to
the deletion of ROP5 (106 parasites) [9,10].
South American stains are much more genetically diverse than those in the North and our
current estimate of the population structure consists of 6 major clades that contain a total of 16
distinct haplogroups [21,22]. Notably, most common haplotypes from South America are also
virulent in mice [23], similar to the type I lineage of North America where this phenotype is
otherwise rare. Importantly, South American strains also exhibit the trait that a single infec-
tious organism is lethal in all conventional laboratory mice (i.e. LD100 = 1) and they do not give
rise to serologically positive surviving animals [23]. Previous studies have shown that ROP5
alleles in North and South American strains are correlated with resistance to IRG coating of
the parasitophorous vacuole [18] and that expression of ROP18 from the South American
strain RUB (type 5) confers virulence to an avirulent type 3 parasite [24]. However, the precise
contributions of ROP5, ROP18, or other genetic factors, to acute virulence in these strains are
unknown. For that reason, we mapped the genetic basis for differences in acute virulence
between the intermediate virulence type 2 ME49 strain and the highly virulent type 10 VAND
strain using a recently conducted genetic cross [25]. The type 2 ME49 parental strain was iso-
lated from a sheep in the USA [26], whereas the type 10 VAND parental strain was originally
isolated from an immunocompetent human adult in French Guiana [27]. Using quantitative
trait locus (QTL) mapping and CRISPR-Cas9 generated knockout (KO) lines we were able to
identify ROP5 as the single major virulence factor underlying the virulence differences in labo-
ratory mice between type 2 and type 10 parasites. Additionally assessment of the contribution
of ROP18 to virulence in several South American strains revealed a stronger phenotype than
has been previously described for North American type 1 strains. These findings demonstrate
that the genetic basis of mouse virulence is conserved across diverse lineages of T. gondii.
Results
Virulence maps to the ROP5 locus in the ME49-FUDRr X VAND-SNFr
cross
We utilized a previously described genetic cross between type 2 ME49-FUDRr and type 10
VAND-SNFr strains [25,28]. Whole-genome sequencing of 24 progeny and mapping based on
genome-wide SNP analysis was previously used to identify the molecular basis of sinefungin
resistance [29]. Here we used the existing genetic map from this cross to analyze virulence of
24 recombinant progeny in CD-1 outbred mice. The parental ME49-FUDRr strain generally
does not cause lethal infection in CD-1 mice and 7 of the progeny inherited this trait, where
most or all of the mice infected with these progeny survived the 30 day course of the
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experiment (Fig 1A). There were 14 progeny that acquired the virulent trait from the
VAND-SNFr parent, exhibiting 75% mortality in CD-1 mice (Fig 1A). Only three progeny
showed an intermediate phenotype, with 50% of the mice succumbing to infection when
infected with these progeny (Fig 1A).
A genome-wide primary QTL scan of virulence (% mortality) run as a continuous pheno-
type generated one significant peak between the physical locations of 0.48 MB and 2.94 MB on
chromosome XII with a log10 of odds (LOD) score of 6.95 (Fig 1B). A second QTL was detected
in the primary scan with a LOD score of 2.54 on chromosome Ia; however, this peak did not
reach significance (Fig 1B). The single peak on chromosome XII accounted for 71% of the
Fig 1. Genetic mapping of the virulence phenotype identified the ROP5 locus as the single major QTL. A) The parents and progeny of the genetic
cross between type 2 ME49-FUDRr and type 10 VAND-SNFr strains were assessed for virulence in 5 outbred CD-1 mice per strain. (B) A QTL scan of the
virulence phenotype generates one significant peak on the left end of chromosome XII with a LOD score of 6.95 and effect size 71%. Genome-wide LOD
significance thresholds were obtained from 10,000 permutation tests, α .05 LOD 2.7. (C) A secondary scan of the virulence phenotype with the locus on
chromosome XII run as an additive covariate. (D) A two-dimensional genome scan with a full model testing for interacting QTLs (top half) and an additive
model testing for multiple QTLs without interaction (bottom half). Genome-wide LOD significance thresholds were obtained from 1,000 permutation tests.
doi:10.1371/journal.pgen.1005434.g001
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effect-size, or variance in the virulence phenotype. A secondary scan with the primary QTL on
XII run as an additive covariate failed to produce additional significant peaks (Fig 1C).
Although no secondary peaks were identified, analysis of the virulence phenotype using a two-
locus model identified a significant interaction between the primary peak on XII and chromo-
some VIIa, with a LOD score of 7.68. This finding is of interest as the known virulence factors
ROP5 and ROP18 are located on chromosomes XII and VIIa, respectively.
Deletion of ROP5 in the VAND strain reduced virulence in mice
Because the peak on XII includes the tandem repeat of the ROP5 gene that has been shown to
be a virulence factor in other strains, we chose to investigate ROP5 further. To delete the large
locus spanning all copies of ROP5 on chromosome XII, we modified the T. gondii CRISPR-
Cas9 plasmid [30] to express two separate single-guide RNAs (sgRNAs). The two sgRNAs
target unique sites upstream and downstream of the ROP5 locus (Fig 2A). When expressed in
T. gondii, the sgRNAs should generate two double-strand breaks in the genome and allow for
replacement of the intervening region with a selection cassette containing homologous regions
outside the sgRNA cut sites. This strategy is expected to generate a knockout of all ROP5 alleles
including the expanded copy number ROP5 genes represented by TGVAND_308090, and two
adjacent single copy genes that encode predicted pseudokinases that are paralogs of ROP5:
TGVAND_308093 and TGVAND_308096 (Fig 2A). We co-electroporated the double-CRISPR
plasmid with a loxP-DHFR-mCherry-loxP selection cassette into VAND and acquired
stable parasites after selection with pyrimethamine. A PCR screen for integration of the loxP-
DHFR-mCherry-loxP selection cassette at the ROP5 locus identified parasite clones that were
positive for homologous integration (Fig 2B) and lacked all ROP5 coding regions (S1A Fig).
Western blot analysis with rabbit α-ROP5 confirmed that no protein expression was detectable
(Fig 2C). Wild type VAND and two different clones of VANDΔrop5 parasites were injected
i.p. into CD-1 mice to test virulence. Only mice infected with wild type parasites succumbed
to infection. Mice infected with VANDΔrop5 survived the course of the experiment, even at
a high dose of 105 parasites (Fig 2D). Surviving mice from these experiments (Fig 2D) were
tested for the generation of T. gondii antibodies via ELISA to ensure they were initially infected
(S2 Fig). To confirm that ROP5 is sufficient for virulence we complemented the VANDΔrop5
parasite with the TOXOM52 cosmid that spans the _308090 tandem ROP5 locus, but does not
include the adjacent _308093 or _308096 genes. TOXOM52 transgenic parasites were positive
by PCR for the ROP5 coding sequence (S1A Fig) and showed wild type levels of ROP5 protein
expression (Fig 2C). Mice infected with VANDΔrop5::TOXOM52 succumbed to infection in a
similar timeframe as those infected with wild type parasites, demonstrating that the tandemly
repeated _308090 ROP5 alleles are sufficient to restore virulence to wild type levels (Fig 2D).
These results confirm that ROP5 is the major locus responsible for virulence differences
between type 2 ME49 and type 10 VAND.
ROP5 is a major virulence factor in Clade B South American strains
TgCtBr5 and TgCtBr18
Genetic crosses have now implicated ROP5 as a major virulence factor using type 1 GT1 [9]
(Clade A), type 2 ME49 (Clade D), type 3 VEG (Clade C) [7,10] and type 10 VAND (Clade F)
parasites as parental strains. These strain types represent a broad, yet incomplete, spectrum of
the global T. gondii genetic diversity (Fig 3A) [21,22]. Given this, we were interested to test the
contribution of ROP5 to virulence in strains from Clade B, a genetically distinct group not rep-
resented by the currently available genetic crosses. Using the double-CRISPR strategy applied
to generate the VANDΔrop5 strain, we created Δrop5 parasites for virulent South American
Virulence of South American Toxoplasma gondii Strains
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type 8 TgCtBr5 and type 4 TgCtBr18 strains. Knockouts were confirmed by PCR screening of
clones for integration of the selection cassette (S3A and S3B Fig), loss of the ROP5 coding
region (S1B and S1C Fig), and loss of ROP5 protein expression by Western blotting (Fig 3B
and 3D). Mice succumbed to infection with wild type strains of TgCtBr5 or TgCtBr18, yet
when mice were infected with either TgCtBr5Δrop5 or TgCtBr18Δrop5 they survived the
Fig 2. ROP5 accounts for virulence phenotype in the type 10 VAND strain. (A) Schematic diagram for
knocking out the ROP5 locus on chromosome XII. Representation of the CRISPR-Cas9 plasmid (green box)
and double CRISPR sgRNAs (yellow boxes), the sgRNA cut sites (lightning bolts), genes at the locus (red
boxes) with copy number estimates of the ROP5 genes (white text in red box), the integration of the DHFR*-
mCherry cassette (pink), and primers used in diagnostic PCR (arrows). (B) Diagnostic PCR showing
integration of the DHFR*-mCherry cassette in two VANDΔrop5 clones, G: GRA1 promoter positive control—
primer 1: 5’ integration—primer 2: 3’ integration—primer Set5-2. (C) Western blot of the VANDΔrop5mutant
and a complemented clone expressing the ToxoM52 cosmid containing ROP5. Probed with α-rabbit ROP5
(IRDye 680: red) and mAb DG52 to SAG1 (IRDye 800: green–control), Stds: protein standards. The separate
panels of the image come from the same gel where the intervening lanes have been removed as they were
not related. (D) CD-1 mice were injected i.p. with indicated number of parasites, five mice per clone. The
percentage of surviving mice was adjusted for those that were not infected, based on serological testing.
doi:10.1371/journal.pgen.1005434.g002
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Fig 3. ROP5 is a virulence factor in South American strains TgCtBr5 and TgCtBr18. (A) Population
genetic network analysis using genome-wide SNPs from 16 Toxoplasma gondii reference strains plus strain
TgCtBr18. Numbers represent the haplogroup of the strain and colors represent the Clade: Clade A (pink),
Clade B (gray), Clade C (blue), Clade D (green), Clade E (yellow), Clade F (purple). (B) Western blot of the
TgCtBr5Δrop5 clones probing with rabbit α-ROP5 (IRDye 680: red) and mAb DG52 against SAG1 (IRDye
800: green–control), Stds: protein standards. (C) CD-1 mice were i.p. injected with indicated number of
parasites, five mice per clone. (D) Western blot of the TgCtBr18Δrop5 clones probing with rabbit α-ROP5
(IRDye 680: red) and mAb DG52 against SAG1 (IRDye 800: green–control), Stds: protein standards. (E) CD-
1 mice were i.p. injected with indicated number of parasites, five mice per clone. The percentage of surviving
mice was adjusted for those that were not infected, based on serological testing.
doi:10.1371/journal.pgen.1005434.g003
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course of the experiment (Fig 3C and 3E). These data demonstrate that ROP5 is also a major
contributor to virulence in Clade B strains of T. gondii.
Loss of ROP18 renders South American strains VAND, TgCtBr5, and
TgCtBr18 avirulent
ROP5 and ROP18 have previously been shown to function together to resist host IRG-medi-
ated parasite killing [16,18]. Although ROP5 plays a dominant role in many strains, the effect
of deleting ROP18 varies with different backgrounds. For example, deletion of ROP18 results in
a delay in the time until death in the RHΔrop18 strain [12] and a modest shift in the LD50 in
GT1Δrop18 strain [30] parasites. Consequently, we assessed the role of ROP18 in the virulence
of South American VAND strains. Using the sgRNA-ROP18 CRISPR disruption strategy
described previously [30], we deleted ROP18 from the VAND-SNFr parental strain. PCR
screening for integration of the DHFR selection cassette at the ROP18 locus was confirmed in
stable clones (S4 Fig), resulting in the loss of ROP18 protein expression, as determined by
Western blotting (Fig 4A). Unlike the delayed death phenotype seen previously for type 1
RHΔrop18 parasites, we observed 100% survival rates for CD-1 mice infected with two different
clones of VANDΔrop18 parasites (Fig 4B), even at a dose of 105 parasites. Virulence was
restored in VANDΔrop18 (Fig 4B) when it was complemented with a ROP18-Ty tagged ver-
sion of the protein (Fig 4A).
To determine how the loss of ROP18 would affect virulence in Clade B strains, we knocked
out ROP18 in TgCtBr5 and TgCtBr18 using the same strategy used in VAND. After pyrimeth-
amine selection we obtained parasite clones that integrated the DHFR selection cassette at
the ROP18 locus (S4B and S4C Fig), resulting in the loss of expression of ROP18 as determined
by Western blotting (Fig 4C and 4E). Similar to type 10 VAND parasites lacking ROP18,
TgCtBr5Δrop18 and TgCtBr18Δrop18 parasites were completely avirulent in CD-1 mice, even
at a dose of 105 (Fig 4D and 4F)
Fig 4. ROP18 is essential for virulence in South American strains VAND, TgCtBr5, and TgCtBr18. (A) Western blot of the VANDΔrop18 and
complemented lines probed with rabbit α-ROP18 (IRDye 680: red) and mAb DG52 against SAG1 (IRDye 800: green–control), Stds: protein standards. (B)
CD-1 mice were injected i.p. with indicated number of parasites, five mice per clone. (C) Western blot of the TgCtBr5Δrop18 clones probing with rabbit α-
ROP18 (IRDye 680: red) and mAb DG52 against SAG1 (IRDye 800: green–control), Stds: protein standards. (D) CD-1 mice were injected i.p. with indicated
number of parasites, five mice per clone. (E) Western blot of the TgCtBr18Δrop18 clones probing with rabbit α-ROP18 (IRDye 680: red) and mAb DG52
against SAG1 (IRDye 800: green–control), Stds: protein standards. (F) CD-1 mice were injected i.p. with indicated number of parasites, five mice per clone.
The percentage of surviving mice was adjusted for those that were not infected, based on serological testing.
doi:10.1371/journal.pgen.1005434.g004
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CNV and allelic structure of ROP5 in South American strains
The locus encoding ROP5 shows evidence of expansion of tandem copies of the gene in differ-
ent strains of T. gondii [10,16]. Alignments of genome-wide sequence to the assembled ME49
chromosomes revealed that the copy number for the ROP5 gene (_308090) varies between
strains, whereas the more divergent _308093 and _308096 ROP5 paralogs that lie adjacent in
the genome are each single copy (Fig 5A) [31]. The number of copies of ROP5 (_308090) (i.e.
copy number variation (CNV)) for each of the strains was estimated by comparing the trace
reads to the CDS, yielding the following estimates: GT1 (5), ME49 (10), VEG (4), TgCtBr18
Fig 5. CNV and phylogenetic analysis of ROP5 copies in VAND, TgCtBr5, TgCtBr18. (A) Copy number variation depth for T, gondii strains across the
ROP5 locus on chromosome XII. Copy number estimates are based on the read depth per base pair normalized to 1X across the respective genome. (B) A
Maximum Likelihood tree for T. gondii strains based on ROP5 amino acid sequences. Only maximum likelihood bootstrap values above 50 are shown. (C)
The sequence identity across all sequences at each position is shown for the ROP5 amino acid sequence alignment. Purple indicates residues at positions
with 100% sequence identity. Yellow indicates less than complete sequence identity and red indicates very low sequence identity at a given position. The
ROP5 pseudokinase domain, catalytic triad, and residues involved in IRGa6 interactions are indicated by orange, black, and red bars, respectively. The
predicted ROP5 allele copy numbers are shown beneath the sequence identity graph along with the amino acid alignments at positions where the respective
codons are evolving under positive selection. The most frequent amino acid residue in a given position of the alignment is highlighted in pink. Amino acid
positions/alignments of the catalytic triad are also shown; only a single codon position within the catalytic triad is evolving under positive selection (indicated
by an asterisk). Allele names for the respective strains used in B and C are based on NCBI entries. Further discussion of the relationship among the alleles is
provided in the results.
doi:10.1371/journal.pgen.1005434.g005
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(6), TgCtBr5 (7), and VAND (8) (Fig 5A and 5B). Previous studies have shown that each strain
contains a dominant allele that is expressed at higher levels based on CNV. Dominant alleles
have been referred to as “C”, while less common alleles were labelled as “A” or “B”, in work
reported by Resse et al., [10], while these two categories were called M for major (C alleles) and
m for minor alleles (B and A alleles) by Behnke et al., [9]. ROP5 alleles in VAND and TgCtBr5
were also previously named using A and B alleles, based on how they grouped phylogenetically
with a collection of various strains including the type 2 strain ME49 [18]. We were able to esti-
mate the CNV for the individual ROP5 alleles from these alignments for the strains VAND
and TgCtBr5 (Fig 5C). These genes can also be defined as major and minor alleles based on
copy number: TgCtBr5-B1 corresponds to the major allele (M), while TgCtBr5-B2 is a minor
allele (m1); VAND-B2 is the major allele (M); VAND-B1, VAND-B3, and VAND-A are minor
alleles (m1-3, respectively).
Although the number of ROP5 copies found in a strain doesn’t correlate with virulence,
amplification of specific alleles types is associated with virulence in the murine model [10,16].
For example, the major alleles shared by type 1 and 3 strains (GT1-M, VEG-M corresponding
to ROP5CI/III) are associated with virulence, while those from type 2 (ME49-M or ROP5CII)
are not [9,10]. To expand on this relationship, we conducted phylogenetic analysis using the
previous sequences for ME49, GT1, VEG [16] and VAND, TgCtBr5 [18] ROP5 alleles that are
available from NCBI. Phylogenetic analysis of the ROP5 protein sequences revealed a lack of
monophyly among the three strain types (Fig 5B). However, most alleles from the virulent
strains group together, with VAND-B1 (m1), VAND-B2 (M), TgCtBr5-B1 (M), and
TgCtBr5-B2 (m1) being closer to GT1-M. This cluster also included the major type 3 allele in
VEG (VEG-M), which is functionally similar to the major allele in type 1 strains (the avirulence
of VEG is due to hypo-expression of ROP18 not a defect in ROP5). In contrast, GT1-m2,
VEG-m2, and VAND-A from virulent parasites group with the avirulent ME49-M and
ME49-m1 alleles (Fig 5B). VAND-B3 appeared as a more divergent allele occurring on a long
branch at the base of the tree (Fig 5B).
The function of ROP5 alleles in virulence may be attributed to differences the polymorphic
surface of ROP5, which interacts with host IRGs and likely contributes to IRG specificity [19].
Indeed, when we analyzed the ratio of non-synonymous to synonymous mutations we detected
23 codon sites evolving under significant positive diversifying selection, with the majority of
codon sites (74% of positive codons) localized within the regions encoding the polymorphic
surface of ROP5 (S1 Table and Fig 5C). Interestingly, one codon site that evolves under positive
diversifying selection was found within the DFG motif that is normally part of the activation
loop in active kinases (S1 Table and Fig 5C). To provide greater insight into the region of
ROP5 that is under diversifying selection, we mapped these residues on the recently described
binding site for Irga6 as revealed by a X-ray co-crystal structure [19]. A majority of the residues
in ROP5 that are under positive selection cluster tightly to a region that interacts directly with
Irga6 (Fig 6A). A total of 13 residues (56.5%) under positive selection are directly at the inter-
face between ROP5 and Irga6 (purple in Fig 6B, S1 Table), as identified by PDBePISA [32,33].
An additional 3 residues (13%) under positive selection are close to the interface and may play
a supporting role in stabilizing the primary interface residues (S1 Table and Fig 6).
Discussion
Our studies extend the application of forward genetic crosses and reverse genetic engineering
using CRISPR-Cas9 to South American strains to provide an expanded framework for examin-
ing the basis of acute virulence in the mouse model. These studies reveal a conserved role for
ROP5 and ROP18 in acute virulence in the mouse, likely due to their previously demonstrated
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role in protecting the parasite from host innate immune responses [12,15]. The identification
of only a single significant QTL in analyzing phenotypic differences among progeny from the
genetic cross between type 2 ME49 and type 10 VAND led to the identification of ROP5 as the
major locus in controlling acute virulence in the mouse. Although ROP18 was not detected in a
primary scan, a two-locus interaction occurred between regions containing ROP5 (chromo-
some XII) and ROP18 (chromosome VIIa), suggesting that these two genes collectively explain
the major virulence differences among diverse strains of T. gondii in the mouse. This prediction
was borne out by reverse genetic engineering of ROP5 and ROP18 disruptant mutants in other
South American strains, the latter of which showed more severe defects in acute virulence than
previously observed in the type 1 background. The widespread importance of these two viru-
lence factors suggests that they evolved before the global spread and divergence of the parasite,
consistent with recent reports that functional alleles of ROP5 and ROP18 also exist in the close
relative Hammondia hammondi [34], even though this parasite is not virulent in mice.
Fig 6. Codons under positive diversifying selection encode amino acid residues at the ROP5BI /IRGa6 interface. (A) Structure of T. gondiiROP5BI
(grey) bound to murine Irga6 (tan) showing amino acid residues under positive diversifying selection (red), ROP5BI residues at the ROP5BI /Irga6 interface
(blue), and residues that are under positive diversifying selection and at the interface (purple). (B) Both panels are a rotation of 60° about the x-axis with
respect to A, showing ROP5BI with Irga6 removed for clarity. The color scheme is as in A. Bottom panel is a surface representation showing the overlap in
surface residues. The top panel shows the position of all amino acid residues under positive diversifying selection.
doi:10.1371/journal.pgen.1005434.g006
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Collectively, these data suggest that ROP5 and ROP18 have been important in the evolution of
these parasites within their rodent hosts, likely due to their interaction with the IRG family.
Despite extensive polymorphism between alleles, the major difference in the contribution of
ROP18 to mouse virulence is due to different expression levels, being high in types 1 and 2, and
very low in type 3 [7,8]. Complementation of a type 3 strain by over-expression of either
ROP18I [8] or ROP18II [7] was sufficient to restore virulence. Additionally previous studies
have shown that complementation of an avirulent type 3 strain with type 1-like alleles of
ROP18 from South American strains results in a similar gain of virulence [24]. Combined with
the fact that ROP18 was not seen as a major QTL in the cross between type 1 and 2, where
ROP5 was mapped [9], these data suggest that different alleles of ROP18 function similarly,
and their differential contribution to virulence is primary due to expression level. Given these
previous findings, it is perhaps not surprising that ROP18 was not identified as a major QTL in
the present cross. However, it was somewhat surprising that ROP5 was identified as the gene
responsible for the majority of difference in acute virulence between type 2 ME49 and type 10
VAND, given the extensive genetic differences between these strains [21,22]. The mechanism
by which ROP18 and ROP5 thwart innate immunity has been well established in North Ameri-
can strain types, where the combination of alleles present in type 1 strains leads to resistance to
IRG loading relative to type 2 or 3 strains [11]. Although we did not test the recruitment of
IRGs directly in this study, the role of ROP5 and ROP18 in the virulence of South American
strains is likely due to their function in resisting host IRG recruitment to the parasitophorous
vacuole. Consistent with this prediction, previous studies have shown that in IFNg-activated
host cells, vacuoles containing virulent VAND (type 10) and TgCtBr5 (type 8) parasites recruit
less Irgb6 than susceptible type 2 and 3 parasites [18].
The only other single peak observed on chromosome Ia was below the threshold of signifi-
cance. In a previous genetic cross between type 1 and 3, a minor QTL was detected on chromo-
some Ia from markers M48 (~330 kbp)–AK4 (~485 kbp) with a LOD score of 2.38 [8].
However, in the present study, the QTL peak on chromosome Ia lies at marker MV24 near the
right end of the chromosome (~1,500 kbp) with a LOD score of 2.54, and a marginal level of
significance. There is also a second non-significant peak in the center of the chromosome from
MV2 (~570 kbp) to MV9 (~830 kbp). These findings suggest that genes on this chromosome
play a minor role in acute virulence in the mouse, although the resolution of the present data is
insufficient to precisely map these or to identify candidate genes.
Although forward genetic mapping allowed us to identify a locus containing ROP5 as
important in the virulence of South American strains, the newly adapted CRISPR-Cas9 tech-
nology was critical for testing its function by reverse genetics. The default DNA damage repair
pathway in T. gondii is nonhomologous DNA end joining, and for this reason the use of a
Δku80 background is important to efficiently generate knockout parasites [35,36]. Several
attempts were made to generate a VANDΔku80 strain for use in this study but all were unsuc-
cessful, perhaps because VAND is a low passage isolate that has not been adapted to in vitro
culture conditions for long periods of time. However, gene disruption using CRISPR-Cas9 is
highly efficient even in wild type KU80 proficient parasites, as shown previously [30], and this
technique was also successfully applied here to diverse strains. We also extended this strategy
by creating a CRISPR-Cas9 plasmid that expressed two sgRNAs targeting sites surrounding a
large genomic locus. This strategy was efficient at deleting the ~30 kb ROP5 locus in three dif-
ferent low-passage South American strains. The acute virulence phenotype of VANDΔrop5
mutant was restored using a cosmid that only contains the ROP5 cluster, but not the adjacent
pseudokinase paralogs, indicating that these adjacent genes contribute little to the phenotype
and that the ROP5 alleles are the primary determinants of acute virulence.
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Phylogenetic analysis revealed that VAND and TgCtBr5 contain ROP5 alleles that are simi-
lar to the major alleles in the virulent type 1 strain GT1, with only minor alleles being similar to
the type 2 strain ME49. Based on this similarity, we decided to complement the VAND ROP5
locus knockout with a cosmid containing the cluster from the type I RH strain. We have not
tested the function of individual alleles in restoring this phenotype, nor complemented directly
with individual VAND alleles, and further testing would be needed to establish if they have
conserved functions. Interestingly, all of the ROP5 alleles contain a functional change in HRD
motif, that forms part of the catalytic triad, where major alleles in the virulent strains (those
related to GT1-M corresponding to ROP5CI) and some minor alleles such as GT1-m1
(ROP5BI) contain “H”, while the major allele in the type 2 strain ME49 (ME49-M, ROP5CII),
and minor alleles such as VAND-A, GT1-m2 (ROP5AI), and VEG-m2 contain a “R”. In con-
trast, VAND-B1 and VAND-B2 alleles show a new residue in the catalytic triad of “L”, which
again is predicted to lack kinase activity. None of these residues is predicted to be active as this
residue is normally a D in active kinases [37]. The functional significance of these changes in
the catalytic triad of ROP5 is unclear as the interface that interacts with IRGs is on the opposite
face of the molecule [19]. However these different alleles also correlate with differences in func-
tion in laboratory mice: the former group, including GT1-M, GT1-m1, and related alleles,
inhibit recruitment of IRGs to the parasitophorous vacuole in vivo, while the later group,
including ME49-M and related alleles, do not [16,17]. The diversity of alleles found in ROP5
suggests that alleles that lack activity in the mouse may be active in others hosts, for example
other rodents or birds.
Previous studies have emphasized that this binding interface is polymorphic in ROP5 [19],
and our analysis of residues that are under strong positive selection in ROP5 further defines
this interface as a cluster of residues that directly interacts with Irga6. Additional nearby poly-
morphic residues in ROP5 may act to influence the Irga6 interaction through allosteric interac-
tions, or they may be important in binding to other polymorphic alleles of Irga6. Importantly,
IRGs also show polymorphism in this region of the molecule [19], suggesting that ROP5 is
under selective pressure for enhanced binding while IRGs have evolved to avoid recognition.
In support of this model, binding of ROP5 to Irga6 has been shown to directly limit polymeri-
zation in vitro [19], as well as to enhance phosphorylation of IRGs by ROP18 in vitro and in
vivo [16]. Collectively, these findings provide evidence for the hypothesis that the polymorphic
regions of ROP5 are evolving under positive diversifying selection driven by interaction with
host innate immunity factors.
We were also able to efficiently delete ROP18 in different genetic backgrounds, demonstrat-
ing the potential of CRISPR-Cas9 for genetic manipulation of diverse strains of T. gondii.
Unlike ROP5 knockouts where all Δrop5 strains tested are equally avirulent despite different
genetic backgrounds, there are large differences in the phenotype of Δrop18 disruptants
between strains. For example, previous studies have reported that deletion of ROP18 in the
type 1 RH strain led to delayed time until death, but not a change in the lethal dose [12] vs. a
several log increase in the lethal dose using the type 1 GT1 strain [30]. In contrast, deletion of
ROP18 in type 4, 8, and 10 strains led to a complete loss of virulence with no animals dying at a
challenge dose of up to 105 (present study). The reasons for these differences are uncertain but
are unlikely to be due to experimental variation in the mouse model since they were obtained
in the same laboratory using a standard protocol that is highly reproducible. Type 1 strains
normally result in lethal infection in all strains of conventional laboratory mice with an inocu-
lum of a single parasite [4,5,6]. In contrast animals infected here with Δrop18mutants in type
4, 8, and 10 did not succumb to infection, yet had very high antibody titers, reflecting an active
infection. Previous studies have stressed that the major contribution of ROP18 in acute viru-
lence appears to be due to expression level differences, and yet all the strains tested here show
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high levels of expression [24]. Hence, it is not immediately clear why the contribution of
ROP18 to acute virulence would vary so extensively among the strains tested here. Once possi-
bility is that the small number of polymorphisms in ROP18 alleles found between type 1 strains
and the isolates studies here may account for these differences. Consistent with this, previous
studies have also shown that virulent alleles of ROP18 are also under diversifying selection
[24]. The marked differences in attenuation with the deletion of ROP18 might also be due to
the relative importance of other genes that contribute to acute virulence. For example, the
active rhoptry kinase ROP17 [20] or the secreted dense granule GRA7 [38], which have been
shown to be important in the type I RH strain, may partially compensate for loss of ROP18 in
some backgrounds. The fact that ROP18 plays a less important role in the RH strain, may also
be due to its passage history, which has been propagated extensively in mice and in vitro since
its original isolation more than 75 years ago [39], resulting in numerous changes that favor
growth. Further studies of the precise function of various ROP18 alleles in different genetic
backgrounds would be necessary to decipher among these alternatives.
Despite their conserved functions in the murine model, ROP5 and ROP18 do not appear to
mediate resistance to IFNg-activated control of replication in human cells [18]. Because
humans lack the expanded IRG family [40], other mechanisms of control likely contribute to
cell autonomous control of replication. However, ROP18 has also been shown to phosphory-
late host cellular protein ATF6-β targeting it for degradation, thus hindering antigen presenta-
tion [41]. This pathway may contribute to disruption of adaptive immunity in hosts other than
murine, including humans. Consistent with this possibility, among human patients with ocular
toxoplasmosis in Columbia, mouse-virulent alleles of ROP18 were correlated with more severe
disease [42]. Additionally, certain South American strains appear to be more virulent in
humans in that they are associated with higher rates of ocular disease in the case of Clade B
[43], and they are associated with severe disease in healthy individuals in the case of Clade F
[44,45,46]. The parasite factors responsible for increased acute disease severity in humans are
unknown, but these traits could be suitable for genetic mapping if appropriate screens were
available for assessing these phenotypes in vitro. Although it is unlikely that resistance in
human cells is a driving factor for evolution of T. gondii virulence, given the fact that humans
are rarely involved in transmission, such traits could represent conserved functions that are
important in multiple vertebrate hosts.
Using forward genetic mapping and reverse genetic engineering with CRISPR-Cas9, we
demonstrate the conserved nature of the ROP5 and ROP18 virulence factors in South Ameri-
can strains of T. gondii. We also found a more dramatic role for ROP18 in the virulence of
these strains than had been appreciated using North American isolates of the parasite. Recent
genetic studies in the house mouse reveal novel alleles of IRGs that are responsible for their
enhanced resistance to otherwise virulent type 1 lineages of T. gondii [47]. The predator-prey
relationship between the house mouse and domestic cat has likely existed for at least 10,000
years in association with human settlement [48]. In contrast, strains harboring similar ROP18
and ROP5 alleles have been estimated to have diverged several million years ago [22]. Collec-
tively these studies suggest that parasite virulence determinants are co-evolving against the
pressure of murine immunity factors in a backdrop of more ancient history that is conserved
among diverse strains of T. gondii.
Materials and Methods
Ethics statement
All animal experiments were conducted according to the U.S.A. Public Health Service Policy
on Humane Care and Use of Laboratory Animals. Animals were maintained in an Association
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for Assessment and Accreditation of Laboratory Animal Care International-approved facility.
All protocols were approved by the Institutional Care Committee at the School of Medicine,
Washington University in St. Louis.
Parasite culture
The parents and progeny of the genetic cross between type 2 ME49-FUDRr and type 10
VAND-SNFr strains [25], and parasite strains TgCtBr5-SNFr and TgCtBr18-SNFr were grown
as tachyzoites in human foreskin fibroblast (HFF) monolayers. The TgCtBr5 and TgCtBr18
strains were made SNF resistant using N-ethyl-N-nitrosourea as described previously [49].
Cultures were maintained in D10 media composed of Dulbecoc’s modified Eagle medium
(DMEM), 10% fetal bovine serum (FBS), gentamycin, and glutamine at 37°C with 5% CO2.
Infected monolayers were scrapped and force passaged through 21 gauge needles to harvest
parasites.
Acute infection and ELISA
CD-1 mice were acquired from commercial vendors (Jackson Labs) and housed under SPF
conditions at Washington University School of Medicine. Acute virulence was determined by i.
p. injection of indicated number of tachyzoites into groups of five 8–12 week old female out-
bred CD-1 mice per experiment. Survival was monitored for 30 days, after which surviving
mice were bled to collect serum for serological testing by enzyme-linked immunosorbent assay
(ELISA), as described previously [50]. The percentage of surviving animals was determined by
the number of animals that succumbed / total number of animals that were infected x 100. Sur-
vival values were corrected for animals that failed to become infected (i.e. those that remained
serologically negative).
Quantitative trait locus analysis for virulence
The virulence phenotype was analyzed by QTL mapping using J/qtl [51] to establish the
genome-wide association of phenotypes with genotypes of progeny from the genetic cross
between type 2 ME49-FUDRr and type 10 VAND-SNFr strains described previously [25]. Viru-
lence QTLs were confirmed by interval mapping based on a one-dimensional genome scan
with 1,000 permutation to generate a log likelihood plot (P< 0.001). Covariant analysis and a
two-dimensional genome scan were conducted using J/qtl to identify minor QTLs and epistatic
interactions, respectively using criteria above.
Double-CRISPR and pUC19-ROP5HR-DHFR*mCherry plasmids
In order to make the double-CRISPR plasmid used to knockout the ROP5 locus, two single
sgRNA CRISPR plasmids were constructed. The pSAG1::CAS9-U6::sgUPRT plasmid
(Addgene #54467) was used as a template to amplify with Set1-1 or Set1-2 primers (S2 Table)
and PCR products were processed using the Q5 Site-Directed Mutagenesis Kit (NEB), as
described previously [30] to create the pSAG1::CAS9-U6::sg5’ROP5 and pSAG1::CAS9-U6::
sg3’ROP5 plasmids. The sgRNA cassette (containing the U6 promoter, sgRNA, and scaffold)
was PCR amplified with Q5 High-Fidelity DNA polymerase (NEB) from the pSAG1::CAS9-
U6::sg3’ROP5 plasmid using Set2-1 primers (S2 Table) that contain terminal KpnI and XhoI
restriction enzyme sites. The sg3’ROP5 cassette PCR product and the pSAG1::CAS9-U6::
sg5’ROP5 plasmid were cut with KpnI/XhoI (NEB), buffer 4 at 37°C overnight, gel purified on
a 1% agarose gel, and purified with the Qiagen Gel Purification Kit (Qiagen). The digested and
purified PCR products and plasmid were ligated using T4 ligase (NEB) at 16°C over-night,
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ligations were transformed into OmniMAX chemically competent cells (Invitrogen), and a cor-
rect clone was identified with KpnI/XhoI restriction fragment mapping. The plasmid named
pSAG1::CAS9-U6::sg5’ROP5-sg3’ROP5 plasmid contains two sgRNAs targeting the 5’ and 3’
side of the ROP5 locus.
To select for the excision of the ROP5 locus in pSAG1::CAS9-U6::sg5’ROP5-sg3’ROP5
transfected parasites, we constructed a selection cassette flanked by homologous regions (HR)
adjacent to the 5’ and 3’ sgROP5 CRISPR cut sites using Gibson Assembly (NEB). Four PCR
fragments were amplified using Q5 High-Fidelity DNA polymerase (NEB) from the following
template/primer pairs: (1) the p-loxP-DHFR-mCherry-loxP plasmid with Set3-1 primers, (2)
VAND genomic lysate with Set 3-2primers, (3) VAND genomic lysate with Set3-3 primers, (4)
the pUC19 plasmid with Set3-4 primers (S2 Table). PCR products were gel purified as above
and combined in a Gibson Assembly reaction (NEB) using manufactures protocol. The reac-
tion was transformed into NEB 5-alpha cells and a correct clone was identified using three dif-
ferent restriction fragment mappings (BamHI/NotI, BamHI/ScaI, and ScaI/NotI) and named
pUC19-ROP5HRs-loxP-DHFR-mCherry. This plasmid was used as a template in a Q5 High-
Fidelity DNA polymerase PCR to amplify the 5’ROP5HR-loxP-DHFRmCherry-loxP-
3’ROP5HR cassette using the Set4-1 primers (S2 Table). This amplified cassette was gel purified
as above for use as a selection cassette in creating ROP5 KO parasites.
ROP5 KOs and complementation
The VAND-SNFr, TgCtBr5-SNFr, and TgCtBr18-SNFr strains were individually electroporated
with the double-CRISPR pSAG1::CAS9-U6::sg5’ROP5-sg3’ROP5 plasmid and a PCR amplified
5’ROP5HR-loxP-DHFRmCherry-loxP-3’ROP5HR selection cassette. Parasites were selected in
2 μM pyrimethamine (Sigma-Aldrich), cloned, and screened by PCR for integration of the
DHFR-mCherry cassette at the ROP5 locus using Set5-1 primers for 5’ integration, Set5-2
primers for 3’ integration, Set5-3 for the ROP5 coding sequence and Set5-4 primers to the
GRA1 promoter as a positive control for the PCR (S2 Table). Knockout parasites were identi-
fied, protein harvested, and Western blotted to confirm the loss of ROP5 protein.
In order to complement with a cosmid containing the DHFR pyrimethamine selection cas-
sette, we excised loxP-DHFR-mCherry-loxP from a VAND ROP5 knockout clone using Cre
recombinase. The VANDΔrop5 #10 strain was electroporated with the pmin-Cre-eGFP plas-
mid [52], cloned without selection, and mCherry negative parasites were screened by immune-
fluorescence assay (IFA) using primary rat aντι-mCherry mAb (Life Technologies) and sec-
ondary goat aντι-rat Alexa Fluor 594 (Life Technologies), to identify a VANDΔrop5Δdhfrm-
Cherry parasite. Sensitivity to 2 μM pyrimethamine was confirmed for
VANDΔrop5ΔdhfrmCherry. To generate the complement, the VANDΔrop5ΔdhfrmCherry
parasite was electroporated with the TOXOM52 cosmid, derived from the type I RH strain
(http://toxomap.wustl.edu/cosmid.html) [53]. The parasites were selected with 2 μM pyrimeth-
amine (Sigma-Aldrich), and clones were screened for expression of ROP5 by IFA using pri-
mary rabbit anti-ROP5 and secondary goat anti-rabbit Alexa-Fluor 594 (Life Technologies).
ROP5 expressing clones were identified, protein harvested, and Western blotted to confirm
wild type levels of expression in the complement, creating VANDΔrop5::ROP5.
ROP18 KOs and complementation
The ROP18 KOs and complement were created as described previously [30]. Briefly, the
VAND-SNFr, TgCtBr5-SNFr, and TgCtBr18-SNFr strains were individually electroporated
with the pSAG1::CAS9-U6::sgROP18 CRISPR plasmid and a PCR amplified selection cassette
containing ROP18 homologous regions flanking a DHFR pyrimethamine resistance marker.
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Parasites were selected with 2 μM pyrimethamine (Sigma-Aldrich), cloned by limiting dilution,
and PCR screened for integration of the selection cassette at the ROP18 CRISPR cut site.
Knockout clones were identified, proteins harvested, and Western blots were run to confirm
the loss of ROP18 protein. To create a complemented strain, the VANDΔrop18 #1 clone was
electroporated with the pSAG1::CAS9-U6::sgUPRT plasmid and a PCR amplified selection cas-
sette containing UPRT homologous regions flanking an IMC1p-ROP18Ty expression con-
struct. Parasites were selected with 10 μM FUDR (Sigma-Aldrich), cloned and screened for
expression of Ty by IFA: using primary α-Ty-BB2 mAb and secondary goat-α-mouse Alexa
Fluor 488 (Life Technologies). ROP18-Ty expressing clones were identified and protein har-
vested, and Western blots were run to confirm wild type expression levels of ROP18 in the
complement, VANDΔrop18::ROP18.
Genomic lysate/PCR screens
Genomic lysates were harvested from various parasite strains for use as templates in PCR
screens. Parasites were grown in HFF monolayers, harvest by scrape/needle pass, spun at 400
rcf and supernatant was aspirated from the parasite pellet. The pellet was suspended in geno-
mic lysate buffer (1X PBS with 10% Taq polymerase buffer (Invitrogen) and 400 ng/μl protein-
ase K (Life Technologies)), the sample was incubated at 37°C for 1hr, 50°C for 30 min, and
95°C for 5–10 min, and spun to pellet debris.
Genomic lysates were used in PCR screens to detect the integration or removal of selection
cassettes. For the ROP5 knockouts and complementation the primer sets outlined in S2 Table
were used, and for the ROP18 disruptants and complementation the primer sets described pre-
viously [30] were used in a Taq polymerase (NEB) PCR. PCR products were run on a 1% aga-
rose gel and imaged on a UV light box.
Protein harvest/western blotting
Parasites were grown and harvested as above, counted on a hemocytometer, the pellet was
resuspended in protein lysate buffer (1X PBS, 1% Triton-X, 1% DNase, 1% protease inhibitors
(Sigma-Aldrich)) to 1 X 106 parasites/μl, vortexed, and spun to pellet debris. Each sample con-
tained protein from 5 X 106 parasites in 1X sample buffer with 10% β-Me (Sigma-Aldrich) and
was incubated for 5–10 min at 95°C. Samples were resolved on a 10% SDS-polyacrylamide
(Bio-Rad) gel at 100V for 1 hr. Gels were transferred to nitrocellulose, blocked in 5% milk, and
probed with (all diluted to 1:10,000) primary—rabbit α-ROP5 or rabbit α-ROP18 and mouse
mAb DG52 α-SAG1 antibodies, and secondary antibodies consisting of goat α-rabbit IgG
IRDye 680 (LI-COR Biosciences) and goat α-mouse IgG IRDye 800 (LI-COR Biosciences). All
Blots were imaged on a LI-COR Odyessy CLx infrared imaging system (LI-COR Biosciences).
Network analysis and CNV
Network analysis using genome wide SNP data from the 16 Toxoplasma gondii reference
genomes and the TgCtBr18 genome (obtained from ToxoDB) was conducted using SplitsTree
v4.4 [54] to generate unrooted phylogenetic networks using a neighbor-net method and 1,000
bootstrap replicates, as previously described [31].
ROP5 alleles used in this study were defined in previous studies [9,18] and were obtained
from NCBI accession records for the following strains: GT1, VEG, and ME49 alleles
(BK008043.1-BK008057.1), VAND alleles (JQ743716.1, JQ743730.1, JQ743760.1, JQ743772.1,
JQ743778.1, JQ743783.1), TgCtBr5 alleles (JQ743734.1, JQ743742.1, JQ743743.1). Briefly,
ROP5 alleles for GT1, VEG and ME49 were previously reconstructed in Behnke et al. [9] by
aligning Sanger sequences of each strain to a reference ROP5 CDS allowing for the
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reconstruction of SNPs patterns. In this case, the Sanger sequences are long enough to combine
overlapping reads containing the same SNP patterns together to define novel alleles, as detailed
in Figure S6 of Behnke et al., [9]. Alleles for VAND and TgCtBr5 were previously defined by
allele-specific amplification and direct sequencing as described in Niedelman et al. [18].
Copy-number variation (CNV) for the ROP5 locus was determined as previously described
[31]. Briefly, NextGen sequence reads of the respective genomes were aligned to the ME49
assembled chromosomes using bowtie2 –end-to-end [55] the average 1X read bases for each
genome and the average read bases for TGME49_308090, TGME49_308093, and
TGME49_308096 were determined using samtools mpileup exported data [56]. The reads sur-
rounding the ROP5 locus for each genome were exported with samtools mpileup and data
were graphed in R. To determine CNV for individual ROP5 alleles, the reads aligning to the
region surrounding TGME49_308090 were exported from the bowtie2 alignment using mpi-
leup and realigned to the ME49 assembled chromosomes using CLC Genomics Workbench.
Reads that corresponded to a particular allele were identified based on SNP pattern and the
allele CNV was estimating by calculating the ratio of allele reads as compared to the total CNV
for the ROP5 locus [9].
Phylogenetic analysis and diversifying selection
DNA sequences were translated and aligned using MUSCLE with Geneious v7.0.4. Phyloge-
netic analysis of the protein sequences was implemented in RAxML [57] using maximum like-
lihood and the JTT+I+G+F model. For maximum likelihood, we used the ModelGenerator v85
[58] to determine the most appropriate amino acid substitution model based on the Akaike
Information Criterion. Positively selected codons were estimated by the Fast Unconstrained
Bayesian AppRoximation method using HyPhy package [59,60]. Posterior probability values
above 0.95 were chosen for codon sites where the distribution of non-synonymous substitution
rates (β) are significantly greater than the synonymous (α) substitution rate.
Molecular modeling studies
Amino acid residues at the ROP5/IRGa6 interface were identified by PDBePISA [32,33] based
on the crystal structure of ROP5BI (corresponding to ROP5 GT1-m1 in the present study)
bound to murine IRGa6 (PDB code 4LV5) [19]. Residues close to the interface were identified
by visual inspection. Figures were generated in PyMOL.
Supporting Information
S1 Fig. Diagnostic PCR for ROP5 CDS. (A-C) Diagnostic PCR showing the absence of ROP5
CDS in VAND (A), TgCtBr5 (B), and TgCtBr18 (C) ROP5 KO strains, and the restoration of
ROP5 in the VAND complemented strains. Set5 primers used, see S2 Table and Fig 2A.
G = GRA1 promoter, 3 = ROP5 CDS (Set5-3 primers).
(TIF)
S2 Fig. ELISA on serum of surviving mice. Sera from all surviving mice in this study were
tested for general Toxoplasma antibody in an ELISA using RH lysate. Positive control (green),
negative controls (red), surviving mice (blue). Red line indicates 99% confidence level cut-off
for calling positive samples.
(TIF)
S3 Fig. Diagnostoc PCR for integration at ROP5. (A,B) Diagnostic PCR showing the integra-
tion of the DHFR-mCherry cassette at the ROP5 locus for TgCtBr5 (A) and TgCtBr18 (B)
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ROP5 KO strains. Set5 primers used, see S1 Table and Fig 2A.
(TIF)
S4 Fig. Diagnostic PCR for integration at ROP18. (A-C) Diagnostic PCR showing the inte-
gration of the DHFR-mCherry cassette at the ROP18 locus for VAND (A), TgCtBr5 (B), and
TgCtBr18 (C) ROP18 KO strains, as in Bang et al.mBIO 2014. Set6 primers used, see S2 Table.
(TIF)
S1 Table. Codons under positive diversifying selection.
(PDF)
S2 Table. Primers used in this study.
(PDF)
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